Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
1,858 results in PubMed
Peer-reviewed biomedical literature from the US National Library of Medicine, most relevant first. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Exagamglogene Autotemcel for Severe Sickle Cell Disease.
Frangoul H, Locatelli F, Sharma A, et al. · N Engl J Med · 2024Multicenter Study, Clinical Trial, Phase III
- CRISPR-Cas9 Editing of the HBG1 and HBG2 Promoters to Treat Sickle Cell Disease.
Sharma A, Boelens JJ, Cancio M, et al. · N Engl J Med · 2023Clinical Trial, Phase I, Clinical Trial, Phase II
- Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.
Kirkham JK, Estepp JH, Weiss MJ, et al. · JAMA Netw Open · 2023Meta-Analysis, Systematic Review
- Circulating mitochondrial DNA is a proinflammatory DAMP in sickle cell disease.
Tumburu L, Ghosh-Choudhary S, Seifuddin FT, et al. · Blood · 2021Clinical Trial, Research Support, N.I.H., Intramural
- Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease.
Esrick EB, Lehmann LE, Biffi A, et al. · N Engl J Med · 2021Clinical Trial, Research Support, N.I.H., Extramural
- Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.
Ataga KI, Kutlar A, Kanter J, et al. · N Engl J Med · 2017Clinical Trial, Phase II, Multicenter Study
- Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trial.
Idowu M, Otieno L, Dumitriu B, et al. · Lancet Haematol · 2025Clinical Trial, Phase II, Clinical Trial, Phase III
- Improvements in health-related quality of life in patients with severe sickle cell disease after exagamglogene autotemcel.
Sharma A, Locatelli F, Bhatia M, et al. · Blood Adv · 2025Clinical Trial, Phase III, Multicenter Study
- Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial.
Grimley M, Davies SM, Shrestha A, et al. · Nat Med · 2025Clinical Trial, Phase I, Clinical Trial, Phase II
- Sickle cell anaemia trial.
Gaston MH, Verter J · Stat Med · 1990Clinical Trial, Multicenter Study
- Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
Charache S, Terrin ML, Moore RD, et al. · N Engl J Med · 1995Clinical Trial, Multicenter Study
- Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.
Gladwin MT, Gordeuk VR, Desai PC, et al. · Lancet Haematol · 2024Randomized Controlled Trial, Clinical Trial, Phase II
- Biomedical applications of maghemite ferrofluid.
Halbreich A, Roger J, Pons JN, et al. · Biochimie · 1998Clinical Trial, Research Support, Non-U.S. Gov't
- Systematic and Meta-Analytic Review: Medication Adherence Among Pediatric Patients With Sickle Cell Disease.
Loiselle K, Lee JL, Szulczewski L, et al. · J Pediatr Psychol · 2016Meta-Analysis, Research Support, N.I.H., Extramural
- The effects of nutritional supplementation for children and adolescents with sickle cell disease: A systematic review and meta-analyses.
Orsi BC, Gorski D, Krul NE, et al. · Clin Nutr · 2025Systematic Review, Network Meta-Analysis
- Updated Worldwide Epidemiology of Inherited Erythrocyte Disorders.
Lippi G, Mattiuzzi C · Acta Haematol · 2020Systematic Review
- Cortisol in sickle cell disease: a systematic review and meta-analysis.
Prussien KV, Burke MM, Gollomp K, et al. · Blood Adv · 2025Systematic Review, Meta-Analysis
- Direct oral anticoagulants in sickle cell disease: a systematic review and meta-analysis.
Rozi W, Rahhal A, Ali EA, et al. · Blood Adv · 2022Letter, Meta-Analysis
- Burden of central nervous system complications in sickle cell disease: A systematic review and meta-analysis.
Lee S, Lucas S, Proudman D, et al. · Pediatr Blood Cancer · 2022Meta-Analysis, Research Support, Non-U.S. Gov't
- The role of preoperative transfusion in sickle cell disease, a systematic review and meta-analysis.
Abdu Y, Rahhal A, Ahmed K, et al. · Blood Rev · 2024Meta-Analysis, Systematic Review
- Malaria chemoprophylaxis in sickle cell disease.
Oniyangi O, Omari AA · Cochrane Database Syst Rev · 2019Meta-Analysis, Research Support, Non-U.S. Gov't
- Electrocardiographic abnormalities in patients with sickle cell disease: A systematic review and meta-analysis.
Taherifard E, Movahed H, Taherifard E, et al. · Pediatr Blood Cancer · 2024Meta-Analysis, Systematic Review
- Screening for cognitive impairment in adults with sickle cell disease: A systematic review and meta-analysis.
Couette M, Roy J, Doglioni DO, et al. · Presse Med · 2023Meta-Analysis, Systematic Review
- Intelligence quotient in paediatric sickle cell disease: a systematic review and meta-analysis.
Kawadler JM, Clayden JD, Clark CA, et al. · Dev Med Child Neurol · 2016Meta-Analysis, Systematic Review
- Biochemical, Cellular, and Proteomic Characterization of Hereditary Spherocytosis Among Tunisians.
Trabelsi N, Bouguerra G, Haddad F, et al. · Cell Physiol Biochem · 2021Clinical Trial
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.